Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet
Disease X Will Kill 80 Million In 36 Hours, WHO Panel Warns International Business Times A report by an independent monitoring body assembled by the World Health Organization (WHO) and The World Bank warned that a new pandemic could wipe ...
Comments
Post a Comment